Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,488
Total Claims
$1.9M
Drug Cost
501
Beneficiaries
$3,744
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+251%
Cost per patient vs peers
$3,744 vs $1,068 avg
+63%
Brand preference vs peers
14.7% vs 9.0% avg
Brand vs Generic
Brand: 1,662 claims · $1.6M
Generic: 9,652 claims · $310K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 232 | $297K |
| Dapagliflozin Propanediol | 147 | $170K |
| Sitagliptin Phosphate | 129 | $164K |
| Finerenone | 108 | $99K |
| Dulaglutide | 58 | $96K |
| Bictegrav/Emtricit/Tenofov Ala | 19 | $77K |
| Semaglutide | 61 | $74K |
| Semaglutide | 63 | $72K |
| Apixaban | 28 | $39K |
| Budesonide/Formoterol Fumarate | 60 | $37K |
| Sitagliptin Phos/Metformin Hcl | 34 | $36K |
| Linagliptin | 21 | $35K |
| Diclofenac Sodium | 166 | $34K |
| Insulin Aspart Prot/Insuln Asp | 25 | $32K |
| Linaclotide | 22 | $25K |
Prescribing Profile
Patient Profile
73
Avg Age
67%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data